Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease
- PMID: 26159898
- DOI: 10.1016/j.lfs.2015.06.026
Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease
Abstract
Aim: Novel effective treatment is urgently needed for sporadic Alzheimer's disease (sAD). M30 ([5-(N-methyl-N-propargylaminomethyl)-8-hydroxyquinoline]) and HLA-20 (5-{4-propargylpiperazin-1-ylmethyl}-8-hydroxyquinoline) are brain permeable, iron chelating compounds with antioxidant activity, showing also neuroprotective activity in animal models of neurodegeneration.Weaimed to explore their therapeutic potential in non-transgenic (non-Tg) rat model of sAD developed by intracerebroventricular administration of streptozotocin (STZ-icv).
Main methods: Therapeutic effects of chronic oral M30 (2 and 10 mg/kg) and HLA20 (5 and 10 mg/kg) treatment on cognitive impairment in STZ-icv rat model were explored by Morris Water Maze (MWM) and Passive Avoidance (PA) tests in neuropreventive and neurorescue paradigms. Data were analysed by Kruskal–Wallis and Mann–Whitney U test (p b 0.05).
Key findings: Five-day oral pre-treatment with M30 and HLA20 dose-dependently prevented development of spatial memory impairment (MWM probe trial-time +116%/M30; +60%/HLA20) in STZ-icv rat model (p b 0.05). Eleven-week oral treatment with M30 (3×/week), initiated 8 days after STZ-icv administration dosedependently ameliorated already developed cognitive deficits in MWM test (reduced number of mistakes 3 months after the STZ-icv treatment — 59%; p b 0.05) and fully restored them in PA test (+314%; p b 0.05). Chronic M30 treatment fully restored (−47%/PHF1;−65%/AT8; p b 0.05) STZ-induced hyperphosphorylation of tau protein and normalized decreased expression of insulin degrading enzyme (+37%; p b 0.05) in hippocampus.
Significance: The results provide first evidence of therapeutic potential of M30 and HLA20 in STZ-icv rat model of sAD with underlying molecular mechanism, further supporting the important role of multi-target ironchelators in sAD treatment.
Keywords: Alzheimer's disease; HLA20 compound; Insulin degrading enzyme; M30 compound; Memory; Streptozotocin; Tau protein.
Similar articles
-
Brain catalase in the streptozotocin-rat model of sporadic Alzheimer's disease treated with the iron chelator-monoamine oxidase inhibitor, M30.J Neural Transm (Vienna). 2015 Apr;122(4):559-64. doi: 10.1007/s00702-014-1307-y. Epub 2014 Sep 25. J Neural Transm (Vienna). 2015. PMID: 25252744
-
Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.Brain Res. 2009 Jul 24;1281:117-27. doi: 10.1016/j.brainres.2009.04.010. Epub 2009 Apr 15. Brain Res. 2009. PMID: 19374888
-
The novel multifunctional, iron-chelating drugs M30 and HLA20 protect pancreatic beta-cell lines from oxidative stress damage.J Pharmacol Exp Ther. 2010 Jun;333(3):874-82. doi: 10.1124/jpet.109.164269. Epub 2010 Mar 17. J Pharmacol Exp Ther. 2010. PMID: 20237072
-
From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.J Alzheimers Dis. 2012;30(1):1-16. doi: 10.3233/JAD-2012-120013. J Alzheimers Dis. 2012. PMID: 22387411 Review.
-
Novel therapeutic approach for neurodegenerative pathologies: multitarget iron-chelating drugs regulating hypoxia-inducible factor 1 signal transduction pathway.Neurodegener Dis. 2012;10(1-4):112-5. doi: 10.1159/000332597. Epub 2011 Dec 9. Neurodegener Dis. 2012. PMID: 22156453 Review.
Cited by
-
Protective Effects of 5-HT1A Receptor Inhibition and 5-HT2A Receptor Stimulation Against Streptozotocin-Induced Apoptosis in the Hippocampus.Malays J Med Sci. 2019 Mar;26(2):40-51. doi: 10.21315/mjms2019.26.2.5. Epub 2019 Apr 30. Malays J Med Sci. 2019. PMID: 31447607 Free PMC article.
-
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.Br J Pharmacol. 2016 Jul;173(13):2080-94. doi: 10.1111/bph.13318. Epub 2015 Dec 1. Br J Pharmacol. 2016. PMID: 26332830 Free PMC article. Review.
-
Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level.Dalton Trans. 2017 Oct 14;46(38):12750-12759. doi: 10.1039/c7dt01344b. Epub 2017 Sep 22. Dalton Trans. 2017. PMID: 28937157 Free PMC article. Review.
-
Antimicrobial Activity and Modulatory Effect of Essential Oil from the Leaf of Rhaphiodon echinus (Nees & Mart) Schauer on Some Antimicrobial Drugs.Molecules. 2016 Jun 8;21(6):743. doi: 10.3390/molecules21060743. Molecules. 2016. PMID: 27338314 Free PMC article.
-
Oxygen Sensing and Signaling in Alzheimer's Disease: A Breathtaking Story!Cell Mol Neurobiol. 2022 Jan;42(1):3-21. doi: 10.1007/s10571-021-01148-6. Epub 2021 Sep 12. Cell Mol Neurobiol. 2022. PMID: 34510330 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous